Home>Tag: Halberd
Aug 10 2020

Halberd Corporation Adds Dr. Abdon Nanhay to Scientific Advisory Board

By |2020-08-10T08:00:04-04:00August 10th, 2020|Featured, Investor News, News|0 Comments

Furthering the Fight Against Covid-19 Internationally Jackson Center, PA, August 10, 2020 – Halberd Corp. (OTC PINK: "HALB") today confirmed the addition of Dr. Abdon Nanhay as a member of the Scientific Advisory Board.  Dr. Nanhay, a Brazilian physician, has over 25 years of experience in health and biological sciences. Dr. Nanhay’s experiences include general ...

Aug 4 2020

Halberd Corporation Secures $2 Million for Covid-19 Research

By |2020-08-04T08:00:29-04:00August 4th, 2020|Featured, Investor News, News|0 Comments

Jackson Center, PA, August 4, 2020 – Halberd Corp. (OTC PINK: "HALB") announced today that they have secured non-dilutive, grant-based funding for their patent pending Covid-19 treatment(s).  Newly formed Nonprofit Organization, Epidemiologic Solutions Corporation, a Louisiana, Internal Revenue Code Section 501(c)(3) application pending, has committed to provide funding of approximately $2,000,000, as required by Halberd ...

Jun 9 2020

Halberd Corporation Appoints Dr. Patricio Reyes to Scientific Advisory Board

By |2020-06-21T23:04:50-04:00June 9th, 2020|Featured, News, Technology|0 Comments

Jackson Center, PA, June 9, 2020 – Halberd Corporation (OTC Pink: HALB) announced the appointment of Dr. Patricio F. Reyes to its Scientific Advisory Board effective immediately  He will report to Halberd’s Chairman, President and CEO, William A. Hartman. Dr. Reyes, MD, FAAN, a board certified neurologist and neuropathologist, is a Board Member of the ...

Go to Top